lorazepam has been researched along with cholestyramine resin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhary, A; Herman, RJ | 1 |
| Herman, RJ; Szakacs, CB; Van Pham, JD | 1 |
| Boctor, MA; Chaudhary, A; Herman, RJ; Lane, R; Szakacs, CB; Woo, D | 1 |
| Chaudhary, A; Herman, RJ; Szakacs, CB | 1 |
1 trial(s) available for lorazepam and cholestyramine resin
| Article | Year |
|---|---|
Disposition of lorazepam in Gilbert's syndrome: effects of fasting, feeding, and enterohepatic circulation.
Topics: Adolescent; Adult; Biological Availability; Cholestyramine Resin; Chromatography, High Pressure Liquid; Diet, Fat-Restricted; Drug Interactions; Enterohepatic Circulation; Fasting; Food-Drug Interactions; Gilbert Disease; Glucuronates; Humans; Infusions, Intravenous; Lorazepam; Male; Neomycin | 1994 |
3 other study(ies) available for lorazepam and cholestyramine resin
| Article | Year |
|---|---|
In vitro binding of lorazepam and lorazepam glucuronide to cholestyramine, colestipol, and activated charcoal.
Topics: Adsorption; Charcoal; Cholestyramine Resin; Colestipol; Kinetics; Lorazepam | 1991 |
Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect.
Topics: Administration, Oral; Adult; Cholestyramine Resin; Drug Interactions; Enterohepatic Circulation; Humans; Injections, Intravenous; Lorazepam; Male; Neomycin | 1989 |
Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins.
Topics: Adolescent; Adult; Cholestyramine Resin; Diabetes Mellitus, Type 1; Humans; Insulin; Lorazepam; Male; Neomycin; Pharmacokinetics | 1995 |